A phase I trial of mushroom powder in patients with biochemically recurrent prostate cancer: Roles of cytokines and myeloid-derived suppressor cells for Agaricus bisporus
-induced prostate-specific antigen responses

Agaricus Bisporus ◽

Phase I Trial ◽

Specific Antigen ◽

Suppressor Cells ◽

Myeloid Derived Suppressor Cells ◽

Recurrent Prostate Cancer

1158. A Phase I/II Dose Escalation Trial of the Intra Prostatic Injection of CG7870, a Prostate Specific Antigen-Dependent Oncolytic Adenovirus in Patients with Locally Recurrent Prostate Cancer Following Definitive Radiotherapy

Molecular Therapy ◽

10.1016/s1525-0016(16)41600-x ◽

2003 ◽

Vol 7 (5) ◽

pp. S446

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Dose Escalation ◽

Specific Antigen ◽

Oncolytic Adenovirus ◽

Definitive Radiotherapy ◽

Locally Recurrent

A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer

Molecular Therapy ◽

10.1016/j.ymthe.2006.02.011 ◽

2006 ◽

Vol 14 (1) ◽

pp. 107-117 ◽

Cited By ~ 152

Author(s):

Eric J. Small ◽

Michael A. Carducci ◽

James M. Burke ◽

Ron Rodriguez ◽

Lawrence Fong ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Metastatic Prostate Cancer ◽

Phase I Trial ◽

Specific Antigen ◽

Oncolytic Adenovirus ◽

Hormone Refractory

Phase I Trial of an Enhanced Prostate-Specific Antigen–Based Vaccine and Anti–CTLA-4 Antibody in Patients with Metastatic Androgen-Independent Prostate Cancer

Clinical Genitourinary Cancer ◽

10.3816/cgc.2007.n.017 ◽

2007 ◽

Vol 5 (5) ◽

pp. 347-350 ◽

Cited By ~ 10

Author(s):

Marc R. Theoret ◽

Philip M. Arlen ◽

Mary Pazdur ◽

William L. Dahut ◽

Jeffrey Schlom ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Specific Antigen ◽

Androgen Independent

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6602019 ◽

2004 ◽

Vol 91 (4) ◽

pp. 688-694 ◽

Cited By ~ 122

Author(s):

M Pavlenko ◽

A-K Roos ◽

A Lundqvist ◽

A Palmborg ◽

A M Miller ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Specific Antigen ◽

Dna Vaccination ◽

Hormone Refractory Prostate Cancer ◽

Hormone Refractory

2152 Bioactivity of CN706, a PSA specific oncolytic adenoviral vector: A phase I trial of in vivo gene therapy for locally-recurrent prostate cancer following radiation therapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(99)90421-2 ◽

1999 ◽

Vol 45 (3) ◽

pp. 356 ◽

Cited By ~ 1

Author(s):

T.L. DeWeese ◽

N. Ramakrishna ◽

A. Demarzo ◽

R. Rodriguez ◽

S. Li ◽

...

Keyword(s):

Prostate Cancer ◽

Gene Therapy ◽

Radiation Therapy ◽

Phase I ◽

Adenoviral Vector ◽

Phase I Trial ◽

Locally Recurrent

A Phase I Feasibility Study of an Intraprostatic Prostate-Specific Antigen–Based Vaccine in Patients with Prostate Cancer with Local Failure After Radiation Therapy or Clinical Progression on Androgen-Deprivation Therapy in the Absence of Local Definitive Therapy

Clinical Genitourinary Cancer ◽

10.3816/cgc.2006.n.024 ◽

2006 ◽

Vol 5 (1) ◽

pp. 89-92 ◽

Cited By ~ 4

Author(s):

Jean-Baptiste Lattouf ◽

Philip M. Arlen ◽

Peter A. Pinto ◽

James L. Gulley

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

Phase I ◽

Androgen Deprivation Therapy ◽

Feasibility Study ◽

Specific Antigen ◽

Local Failure ◽

Clinical Progression ◽

Definitive Therapy

Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial

International Journal of Hyperthermia ◽

10.1080/02656730601175479 ◽

2007 ◽

Vol 23 (3) ◽

pp. 315-323 ◽

Cited By ~ 213

Author(s):

M. Johannsen ◽

U. Gneveckow ◽

K. Taymoorian ◽

B. Thiesen ◽

N. Waldöfner ◽

...

Keyword(s):

Quality Of Life ◽

Prostate Cancer ◽

Magnetic Nanoparticles ◽

Phase I ◽

Phase I Trial ◽

Prospective Phase ◽

Locally Recurrent

Interpreting Testosterone and Concomitant Prostate Specific Antigen Values during Androgen Deprivation Therapy for Recurrent Prostate Cancer

The Journal of Urology ◽

10.1097/ju.0000000000001946 ◽

2021 ◽

Author(s):

Samuel Tremblay ◽

Lily Summers-Trasiewicz ◽

Frédéric Pouliot ◽

Juanita M. Crook ◽

Keyue Ding ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Specific Antigen ◽

Androgen Deprivation ◽

Recurrent Prostate Cancer

Clinical Protocol: Phase I Study of an Adenovirus/Prostate-Specific Antigen Vaccine in Men with Metastatic Prostate Cancer

Human Gene Therapy ◽

10.1089/hum.2006.17.ft-168 ◽

2006 ◽

Vol 0 (0) ◽

pp. 060123080936010

Author(s):

David M. Lubaroff ◽

Badrinath Konety ◽

Brian K. Link ◽

Timothy L. Link ◽

Tammy Madsen ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Study ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Clinical Protocol ◽

Antigen Vaccine

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer

Cancer Immunology Immunotherapy ◽

10.1007/s00262-011-1193-1 ◽

2011 ◽

Vol 61 (7) ◽

pp. 1137-1147 ◽

Cited By ~ 55

Author(s):

Douglas G. McNeel ◽

Heath A. Smith ◽

Jens C. Eickhoff ◽

Joshua M. Lang ◽

Mary Jane Staab ◽

...

Keyword(s):

Prostate Cancer ◽

Phase I ◽

Phase I Trial ◽

Androgen Deprivation ◽

Short Term